Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Trump’s Rx Pricing Order: The Best-Case And Worst-Case Scenarios
May 12 2025
•
By
Derrick Gingery
Many stakeholders want more detail about President Trumps MFN executive order.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access